My NCBI | Sign In
RSS Settings
  • Search: Sesmilo G[au]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 17

    1.

    A short acute octreotide test for response prediction of long-term treatment with somatostatin analogues in acromegalic patients.

    Halperin I, Nicolau J, Casamitjana R, Sesmilo G, Serra-Prat M, Palomera E, Puig-Domingo M.

    Horm Metab Res. 2008 Jun;40(6):422-6. Epub 2008 Apr 7.PMID: 18393173 [PubMed - indexed for MEDLINE]Related articles

    2.

    [Polycystic ovary syndrome and cardiovascular risk]

    Sesmilo G, Gonzàlez-Sastre F.

    Med Clin (Barc). 2007 Sep 8;129(8):297-8. Spanish. No abstract available. PMID: 17878024 [PubMed - indexed for MEDLINE]Related articles

    3.

    Endocrine evaluation of patients after brain injury: what else is needed to define specific clinical recommendations?

    Sesmilo G, Halperin I, Puig-Domingo M.

    Hormones (Athens). 2007 Apr-Jun;6(2):132-7. Review. No abstract available. PMID: 17704044 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Laparoscopic surgery in patients with sporadic and multiple insulinomas associated with multiple endocrine neoplasia type 1.

    Fernández-Cruz L, Martínez I, Cesar-Borges G, Astudillo E, Orduña D, Halperin I, Sesmilo G, Puig M.

    J Gastrointest Surg. 2005 Mar;9(3):381-8.PMID: 15749601 [PubMed - indexed for MEDLINE]Related articles

    5.

    Pheochromocytoma.

    Fernández-Cruz L, Puig-Domingo M, Halperin I, Sesmilo G.

    Scand J Surg. 2004;93(4):302-9. Review. No abstract available. PMID: 15658672 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Measurement of free testosterone in normal women and women with androgen deficiency: comparison of methods.

    Miller KK, Rosner W, Lee H, Hier J, Sesmilo G, Schoenfeld D, Neubauer G, Klibanski A.

    J Clin Endocrinol Metab. 2004 Feb;89(2):525-33.PMID: 14764757 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Effects of a growth hormone receptor antagonist on bone markers in acromegaly.

    Fairfield WP, Sesmilo G, Katznelson L, Pulaski K, Freda PU, Stavrou S, Kleinberg D, Klibanski A.

    Clin Endocrinol (Oxf). 2002 Sep;57(3):385-90.PMID: 12201832 [PubMed - indexed for MEDLINE]Related articles

    8.

    Cardiovascular risk factors in acromegaly before and after normalization of serum IGF-I levels with the GH antagonist pegvisomant.

    Sesmilo G, Fairfield WP, Katznelson L, Pulaski K, Freda PU, Bonert V, Dimaraki E, Stavrou S, Vance ML, Hayden D, Klibanski A.

    J Clin Endocrinol Metab. 2002 Apr;87(4):1692-9.PMID: 11932303 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Inflammatory cardiovascular risk markers in women with hypopituitarism.

    Sesmilo G, Miller KK, Hayden D, Klibanski A.

    J Clin Endocrinol Metab. 2001 Dec;86(12):5774-81.PMID: 11739438 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Effects of growth hormone (GH) administration on homocyst(e)ine levels in men with GH deficiency: a randomized controlled trial.

    Sesmilo G, Biller BM, Llevadot J, Hayden D, Hanson G, Rifai N, Klibanski A.

    J Clin Endocrinol Metab. 2001 Apr;86(4):1518-24.PMID: 11297577 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Androgen deficiency in women with hypopituitarism.

    Miller KK, Sesmilo G, Schiller A, Schoenfeld D, Burton S, Klibanski A.

    J Clin Endocrinol Metab. 2001 Feb;86(2):561-7.PMID: 11158009 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency. A randomized, controlled clinical trial.

    Sesmilo G, Biller BM, Llevadot J, Hayden D, Hanson G, Rifai N, Klibanski A.

    Ann Intern Med. 2000 Jul 18;133(2):111-22.PMID: 10896637 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Effects of nicotinamide and intravenous insulin therapy in newly diagnosed type 1 diabetes.

    Vidal J, Fernández-Balsells M, Sesmilo G, Aguilera E, Casamitjana R, Gomis R, Conget I.

    Diabetes Care. 2000 Mar;23(3):360-4.PMID: 10868866 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Genetic and clinical characterisation of maturity-onset diabetes of the young in Spanish families.

    Costa A, Bescós M, Velho G, Chêvre J, Vidal J, Sesmilo G, Bellanné-Chantelot C, Froguel P, Casamitjana R, Rivera-Fillat F, Gomis R, Conget I.

    Eur J Endocrinol. 2000 Apr;142(4):380-6.PMID: 10754480 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Withdrawal of long-term physiological growth hormone (GH) administration: differential effects on bone density and body composition in men with adult-onset GH deficiency.

    Biller BM, Sesmilo G, Baum HB, Hayden D, Schoenfeld D, Klibanski A.

    J Clin Endocrinol Metab. 2000 Mar;85(3):970-6.PMID: 10720025 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Role of thyroid hormones on serum leptin levels.

    Sesmilo G, Casamitjana R, Halperin I, Gomis R, Vilardell E.

    Eur J Endocrinol. 1998 Oct;139(4):428-30.PMID: 9820621 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Guar gum in the treatment of NIDDM.

    Sesmilo G, Coves MJ, Gomis R.

    Diabetes Care. 1995 Apr;18(4):584-5. No abstract available. PMID: 7497877 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Search details

    » See more...

    Recent activity